Skip to content

ENZO BIOCHEM, INC.

CIK 0000316253

← back to feed
Revenue (TTM)
$27.97M
+2.7% YoY Q3 Jun 2025
Net Income (TTM)
−$10.72M
−228.5% YoY Q3 Jun 2025
EPS Diluted (TTM)
−$0.21
−224.4% YoY Q3 Jun 2025
Gross Margin
28.1%
Q3 Jun 2025
Operating Margin
-38.1%
Q3 Jun 2025
Net Margin
-38.3%
Q3 Jun 2025
Free Cash Flow (TTM)
−$39.43M
Q3 Jun 2025
Cash
$36.69M
Q3 Jun 2025
Total Debt
$278K
Q3 Jun 2025
Shares Outstanding
52.4M sh
Q3 Jun 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings